CADL
Price
$8.79
Change
+$0.37 (+4.39%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
617.67M
77 days until earnings call
Intraday BUY SELL Signals
MGX
Price
$1.33
Change
-$0.00 (-0.00%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
49.32M
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs MGX

Header iconCADL vs MGX Comparison
Open Charts CADL vs MGXBanner chart's image
CADL vs MGX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CADL vs. MGX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a StrongBuy and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (CADL: $8.43 vs. MGX: $1.33)
Brand notoriety: CADL and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 89% vs. MGX: 108%
Market capitalization -- CADL: $617.67M vs. MGX: $49.32M
CADL [@Biotechnology] is valued at $617.67M. MGX’s [@Biotechnology] market capitalization is $49.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CADL and MGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while MGX’s TA Score has 5 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 5 bearish.
  • MGX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MGX is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а +6.04% price change this week, while MGX (@Biotechnology) price change was -2.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

CADL is expected to report earnings on Aug 19, 2026.

MGX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($618M) has a higher market cap than MGX($49.3M). CADL YTD gains are higher at: 49.204 vs. MGX (-17.901). CADL has higher annual earnings (EBITDA): -50.3M vs. MGX (-86.79M). CADL has more cash in the bank: 195M vs. MGX (184M). MGX has less debt than CADL: MGX (41.7M) vs CADL (49.3M). MGX has higher revenues than CADL: MGX (30.9M) vs CADL (0).
CADLMGXCADL / MGX
Capitalization618M49.3M1,254%
EBITDA-50.3M-86.79M58%
Gain YTD49.204-17.901-275%
P/E RatioN/AN/A-
Revenue030.9M-
Total Cash195M184M106%
Total Debt49.3M41.7M118%
TECHNICAL ANALYSIS
Technical Analysis
CADLMGX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
MGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRPIX53.01N/A
N/A
T. Rowe Price Value I
PZVMX12.92N/A
N/A
Pzena Mid Cap Value Investor
WBSRX39.00N/A
N/A
William Blair Small Cap Growth R6
MGRIX26.87N/A
N/A
Marsico Growth
SEQUX196.91-2.60
-1.30%
Sequoia

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with AURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-0.94%
AURA - CADL
47%
Loosely correlated
-3.96%
RXRX - CADL
43%
Loosely correlated
-4.62%
CRBU - CADL
43%
Loosely correlated
-4.32%
MGX - CADL
41%
Loosely correlated
+1.53%
NKTX - CADL
40%
Loosely correlated
-7.32%
More